Cogora: Market Access provides strategy and evidence-generation solutions that maximise the return-on-investment of your product throughout its lifecycle.
Our deep engagement with the payer and clinician community, coupled with in-depth knowledge of reimbursement structures and requirements, allows us to provide detailed strategic advice on the health-economic and clinical data required to ensure reimbursement and uptake of your product.
Based on a strategic review of your and your competitors’ product profiles, we then help identify how to position your product to ensure optimal uptake, how to best differentiate yourself from competitors and how to demonstrate maximum value to payers.
When additional data are needed to support your market access strategy, we offer bespoke evidence-generation services such as systematic literature reviews. We also use available data to create impactful value messages and value demonstration tools to support your payer interactions.
- 3 million rows of prescribing data used for e.g. landscape assessments and payer value demonstration tools added per month
- Network of over 200 payers across Europe and North America
- 600+ payer discussions last year
- 25 International advisory boards each year
But our services do not end there. To ensure our products and services provide maximum value to your team we also offer onsite training on how to use our value demonstration tools during payer interactions and objection handling.
Our services include:
- Market access strategy development
- Payer and value demonstration tools
- Landscape assessments
- Systematic literature reviews
Read some of our case studies for examples of how Cogora: Market Access have supported our other clients.
Developing a data tool
We created an interactive data tool that helped sales representatives to engage more effectively with medicine optimisation teams.
Global market access project
We analysed the global market for our client’s product and provided impactful strategic recommendations.
Read some of our report showing how we use our data and community to produce market access insights.
General Practice Prescribing Trends in England and Wales – 2015 Annual Review
Click for more info and download